with molecular rules, understanding these rules of ecological regulation enables us to diagnose what is ailing ecosystems, and potentially, to cure them". Here, one begins to lose the thread in a tangle of myriad examples and this reader began to skim a bit.
Nevertheless, one lesson is reiterated by Carroll and we are getting it: it is the double negative logic againpopulations of baboons, or bay scallops or cancers are repressed by predators or 'tumour suppressors'. So when one sees baboons or scallops change in population numbers, the best advice is to look up the food chain to fi nd the cause. In the case of scallops their predators (rays) increased… because their predators, the sharks decreased…because…well, you can guess who is responsible.
More short stories follow about the manipulation of populations in the wild: one example is the reintroduction of wolves into Yellowstone Park. The wolves were a success; paradoxically they helped aspen regrowth and boosted beaver numbers in the park. Food chains and population numbers are again the explanation. Then Carroll is back in Africa, reviewing personally the hugely successful restoration of wildlife in Gorongoso National Park by restocking and protection.
Here the account becomes even more discursive, as if whatever negative regulation that ought to be controlling Carroll's inherent tendency to ramble has been lifted further and we receive the full force of his stream of consciousness. Reading was a bit like watching many modern TV programmes on science, where the makers seem to be worried that we the public have a weak and limited concentration that cannot be kept active simply by the power of an argument, and that we need entertaining diversions. But ideas continuously built in front of us, piece by piece, can also grip a reader, and often Carroll demonstrates this by recounting his stories with clarity. Also the asides, the lives of some great scientists, have defi nite value, and even the diversions are sometimes diverting. But on balance, I would have urged more editorial discipline in the crafting of this book. Overall, as I read The Serengeti Rules, I was prepared to be captivated by Carroll's central idea that ecology, molecular biology, biomedicine and genetics all include a common logic, but for me that thesis fl itted in and out of sight, like a butterfl y in a sunlit glade.
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The interdependence of everything. The bee depends on the fl ower for food, and the fl ower depends on the bee for pollination. The spider hides under the fl ower to catch the bee. Sean Carroll's new book focuses on the interdependence of life. Photo by Peter Lawrence. What turned you on to biology in the fi rst place? I fi rst studied medicine and mathematics. An unusual combination, so let me explain: I grew up in Budapest, Hungary. My father was a professor of computer science, working on nonlinear dynamics and its applications, and my mother is a pianist. For me, talking about and doing mathematics at home was as natural as for other kids watching TV or playing outside with friends. I liked mathematics a lot, but for idealistic reasons I started medical school. After a year, however, I felt that I needed to develop my thinking ability too, so I then started to study mathematics as well. I did the two in parallel. It was tiring but very rewarding. Towards the end of medical school, I wished to have a deeper understanding of living systems, especially to get insights into how the different parts of an organism are controlled and organized by a central unit, the brain. I did not feel ready to treat patients, as I did not have a coherent picture of the 'machine' I would be repairing. So I looked into ways of doing research in neuroscience.
Botond Roska
And what drew you to your specifi c fi eld of research? A dinner conversation with Frank Werblin, a neurophysiologist, later to be my PhD supervisor. My father was working on a computer structure that combined both analogue processing and logic. Frank and my father met frequently because they felt it should be possible to model the retina with such a computer. I was present at some of those R224 Current Biology 26, R219-R228, March 21, 2016 ©2016 Elsevier Ltd All rights reserved conversations and could grasp that the retina is a brain structure which could be understood in the kind of detailidentifi ed neurons, connections, and dynamic computations -that interested me. At that time, however, I was not aware that the number of different neuronal cell types and connections are very large, even in a seemingly simple structure as the retina. This diversity makes it very hard to understand how particular computations are achieved. It was Connie Cepko, my mentor in molecular biology and virology at Harvard, who taught me the almost limitless ways we can genetically label and manipulate cells using tools from molecular biology and virology. This enables one to light up and manipulate neurons and their connections and, therefore, understand how a computation is achieved.
Who were your key early infl uences?
My four teachers: Veronika Adam, who introduced me to neuroscience; Frank Werblin, who taught me neurophysiology; Markus Meister, who mentored me in neuronal computation; and Connie Cepko, who was my mentor in genetics and virology. And two friends: Jose Sahel, who taught me how to think in translational medicine; and Rava da Silveira, who I have discussed problems in neuroscience with for a long time. Everything I do is infl uenced by them in various ways.
Do you have a scientifi c hero? Winfried
Denk is a person whose questions always strike me as ones that come from a person who thinks very deeply. I tremendously enjoy being questioned by him, and I then think about his questions and their implications for a long time.
Do you have a favourite paper or science book? Principia Mathematica by Alfred Whitehead and Bertrand Russell. In my view, this work is the deepest insight into how we humans think and into the logical basis of scientifi c discussions. My guess is that I also quite like Principia Mathematica because this is one of the very few scientifi c works that I feel I can truly understand (after a lot of reads).
What is the best advice you've been given? Stay inventive. Being inventive makes for trouble in publishing the results but this is, for me, the essence of doing and enjoying science. There are many ways one can be inventive: in the way one asks a question; in creating new technologies; and looking at problems from quite different perspectives or by solving problems in new ways. I think inventive people share some common properties: they are playful, they dream a lot, they are focused when necessary and single-minded, and they dislike administration and repetitive tasks.
If you would not have made it as a scientist, what would you have become?
A cellist. I wanted initially to become a cellist but, because of an accident, I couldn't continue. This is why I started medical school. Art and science are very close for me. Both need dedication, time, focus, and inventiveness, and both are tremendously enjoyable. A Bach suite, a paper by Horace Barlow or Kolmogorov, or a painting by Picasso, all bring a similar intellectual fulfi lment for me.
What is your greatest research ambition? To get insights into neuronal circuit computations of the human brain and use this understanding to advance medicine. While model organisms offer tractable ways to learn about conserved principles in neuronal circuit function and to establish new methods, the long-term aim of understanding computations of the healthy and diseased human brain at the resolution of individual neurons is something that drives me. As far as medicine, it is my frequent discussions and collaborations with a very close friend, Jose Sahel, a clinician, which inspires me to contribute more. My greatest ambition in medicine is to have at least one blind person who regains some vision using a method that my research helped to develop.
If you had to choose a different fi eld of biology, what would it be?
Perhaps the control of gene expression. I think the problem of how DNA relates to RNA, in different cell types and across time, is still a core and unsolved one in biology.
Which of your papers are you most proud of? It is always the latest one we've published. Currently we are looking into ways of understanding the neuronal circuit defects underlying specifi c neurological symptoms in patients. One approach we think is possible is to investigate genetic diseases in which the affected gene is expressed in specifi c neuronal types and in which the gene, cell type, and participating circuit are conserved across species. An example of such an approach was a paper my colleagues and I published recently (Yonehara et al. (2016) , Neuron 89, [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] : in this study, we worked simultaneously with human patients and with mutant mice, which was enlightening. Do you feel a push towards more applied science? I really appreciate applied science. Once we understand a process deeply it is natural that we try to convert this knowledge into a technology that benefi ts society. Medicine, as an applied science, is particularly close to me, as this was my original training. I hope that some of the fi ndings from my lab will contribute to the advancement of medicine.
Which aspect of science, your fi eld or in general, do you wish the general public knew more about? I wish the public would appreciate more the stochastic nature of things around and inside us. I think we often make mistakes in our judgment because we do not remember that natural processes are stochastic. It is better and wiser to think in terms of probabilities of events than to think about individual events.
Do you think there is too much emphasis on big data-gathering collaborations as opposed to hypothesis-driven research by small groups?
Quite often the problems we are interested in 'solving' in biology have a similar structure. We observe a phenomenon and then try to explain the phenomenon by the dynamic interactions of known elements at a given hierarchical level, such as at the level of molecules, cell types, or brain regions. Big data gathering is invaluable for comprehensively describing the elements and possible interactions at a given hierarchy. The next step is to fi nd a fi nite number of elements and interactions that are most relevant and important for a given phenomenon; then to prove, using experimentation and modelling, whether the chosen set of elements and interactions together are indeed enough to explain a large or relevant part of the chosen phenomenon. We could call this part 'understanding' (of the phenomenon). It seems to me that small groups, with different expertise and skills, working on the same topic helps considerably for both choosing relevant phenomena to be solved and for putting together the pieces and coming to a conclusion. The reason for this is because, fi rst, we do not have a high-throughput way of determining what is relevant and, second, experiments, especially in vivo, are so complicated that we have to use our inventive mind to suggest a few experiments that will provide the most convincing evidence. Nevertheless, our understanding of the workings of living organisms is so small and we progress so slowly that I am sure that we will need to re-evaluate from time to time how we conduct biological research. How were they discovered? SERKs were initially described as embryogenic markers in carrot cell suspension cultures, hence the name. One of the fi ve SERK proteins in Arabidopsis, SERK3, was early on shown to be a positive regulator of the brassinosteroid growth signaling pathway.
What do they do? SERKs control diverse aspects of plant development such as brassinosteroid-and phytosulfokine-dependent growth, somatic embryogenesis, male sporogenesis and stomatal patterning. SERKs form an integral part of the plant immune system and regulate cell death.
Quick guide
How do they do that? One of the best characterized functions for SERKs is in brassinosteroid signal transduction. Overexpression of SERK3 was initially found to rescue weak loss-of-function alleles of the LRR-RK BRI1, the receptor for growth-promoting brassinosteroids. Loss-of-function of multiple SERKs reduces the plant's sensitivity to brassinosteroids, suggesting that SERKs are involved in hormone sensing and that they act redundantly in brassinosteroid signaling. Upon brassinosteroid perception, BRI1 and SERKs interact at the plasma-membrane. This interaction renders their kinase domains competent to trans-phosphorylate each other, which in turn switches on the cytoplasmic side of the brassinosteroid signaling pathway.
What's the mechanism? The molecular function of SERK proteins became clear when the structure of the extracellular LRR domain of BRI1 was resolved. In contrast to human LRR receptor proteins (Toll-like receptors), which have horseshoe-shaped LRR domains that homodimerise upon ligand-binding, the LRR domains of plant RKs are spiral shaped. This special shape does not allow for ligand-dependent homodimerization. Instead, plant LRRRKs require a shape-complementary co-receptor protein, which contributes to ligand binding, and which mediates receptor activation. SERKs turned out to be these co-receptors for different LRR-RKs. In the case of BRI1, brassinosteroid binding generates a docking platform for the smaller LRR domain of SERKs. The hormone acts as a molecular glue, driving the hetero-dimerisation of BRI1 with its SERK co-receptor. Other LRR receptor kinases, such as the innate immune receptor FLS2 or the peptide hormone receptor PSKR, recruit SERKs in very similar ways, despite binding drastically 
